Xiaoming Yi
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Aging top 5%
Papers in
-
- RNA Interference and Gene Delivery 3
- Epigenetics and DNA Methylation 3
- Advanced biosensing and bioanalysis techniques 3
- RNA Research and Splicing 2
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 3
- Co-authors
- Jerry W. Shay (3 shared papers)Woodring E. Wright (3 shared papers)Chaopeng Tang (11 shared papers)Dara L. Aisner (2 shared papers)Valerie M. Tesmer (2 shared papers)Wenquan Zhou (13 shared papers)Joseph A. Baur (1 shared paper)Haowei He (10 shared papers)
- Journals
- Frontiers in Oncology (3 papers)Molecular and Cellular Biology (2 papers)Toxicology and Applied Pharmacology (1 paper)Oncotarget (1 paper)Cancer Biomarkers (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaoming Yi
29 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 88
- Cancer Research 305
- Aging 39
- Physiology 497
- Molecular Biology 697
- Biotechnology 69
Countries citing papers authored by Xiaoming Yi
This map shows the geographic impact of Xiaoming Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoming Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoming Yi more than expected).
Fields of papers citing papers by Xiaoming Yi
This network shows the impact of papers produced by Xiaoming Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoming Yi. The network helps show where Xiaoming Yi may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoming Yi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 172 | |
| 2 | 2001 | 167 | |
| 3 | 1999 | 136 | |
| 4 | 1999 | 102 | |
| 5 | 2016 | 83 | |
| 6 | 2005 | 75 | |
| 7 | 2017 | 64 | |
| 8 | 2018 | 62 | |
| 9 | 2015 | 52 | |
| 10 | 2018 | 39 | |
| 11 | 2022 | 38 | |
| 12 | Downregulation of miR-129 in peripheral blood mononuclear cells is a diagnostic and prognostic biomarker in prostate cancer. | 2015 | 25 |
| 13 | 2017 | 18 | |
| 14 | 2016 | 17 | |
| 15 | 2017 | 17 | |
| 16 | 2008 | 13 | |
| 17 | 2021 | 12 | |
| 18 | 2021 | 12 | |
| 19 | 2020 | 8 | |
| 20 | 2024 | 7 |
About Xiaoming Yi
Xiaoming Yi is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Physiology and Civil and Structural Engineering, having authored 31 papers that have together received 1.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (5 papers), Telomeres, Telomerase, and Senescence (4 papers), Cancer-related molecular mechanisms research (4 papers), RNA Interference and Gene Delivery (3 papers), Epigenetics and DNA Methylation (3 papers), MicroRNA in disease regulation (3 papers), Advanced biosensing and bioanalysis techniques (3 papers) and RNA Research and Splicing (2 papers). The work is most often cited by research in Cancer Research (305 citations), Aging (39 citations), Physiology (497 citations), Molecular Biology (697 citations) and Biotechnology (69 citations). Xiaoming Yi has collaborated with scholars based in China and United States. Frequent co-authors include Jerry W. Shay, Woodring E. Wright, Chaopeng Tang, Dara L. Aisner, Valerie M. Tesmer, Wenquan Zhou, Joseph A. Baur, Haowei He, Jingping Ge and Isabelle Savre‐Train. Their work appears in journals such as Frontiers in Oncology, Molecular and Cellular Biology, Toxicology and Applied Pharmacology, Oncotarget and Cancer Biomarkers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.